(TSX-V:CMC),(Pinksheets:CWSFF),(PinkSheets:CWSFF), THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Nov. 10, 2025 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company“) is pleased to announce that it has closed a tranche of its non-brokered private […]
(NASDAQ:GLTO), Acquisition of Damora and concurrent oversubscribed $285 million private investment positions the company to advance potentially best-in-class portfolio to improve outcomes in patients with Myeloproliferative Neoplasms Damora Therapeutics, the sixth company launched based on assets developed by Paragon Therapeutics, is advancing a portfolio of anti-mutant calreticulin (mutCALR) targeted therapies, led by DMR-001, a potentially
(NASDAQ:BTDR), – $169.7 million revenue, up 173.6% year-over-year– $43.0 million adjusted EBITDA, up from negative $7.9 million last year– Expanding and accelerating AI strategy across multiple initiatives– Achieved 41.2 EH/s of self-mining at the end of October, 2025– Commenced SEALMINER A3 mass production– Early SEAL04 samples have demonstrated 6-7 J/TH power efficiency at the chip
(NASDAQ:EVGO), Total revenue of $92.3 million in the third quarter, representing an increase of 37% year-over-year. Charging network revenue totaled a record $55.8 million in the third quarter, an increase of 33% year-over-year, representing the 15th consecutive quarter of double-digit year-over-year charging revenue growth. Network throughput reached a record 95 gigawatt-hours (“GWh”) in the third
(NASDAQ:CRVO), Aligned with U.S Food and Drug Administration (FDA) on design of planned Phase 3 clinical trial of neflamapimod in patients with dementia with Lewy bodies (DLB) Reported 32-week data from Phase 2b RewinD-LB trial showing neflamapimod treatment in patients with DLB had a durable beneficial effect on clinical progression and resulted in substantial reductions
(NasdaqGM:ATAI), A 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 12 mg, 8 mg or 0.3 mg dose in the core study of the Phase 2b clinical trial produced additional rapid, clinically meaningful antidepressant effects that were sustained for up to eight weeks Patients who received an active
(NASDAQ:VFF), Consolidated Net Sales Increased 21% YoY to $66.7 Million; International Export Sales Increased 758% Consolidated Net Income from Continuing Ops of $10.8 Million or $0.09 Per Share, Up YoY and Sequentially Consolidated Adjusted EBITDA of $20.2 Million or 30.3% of Sales; Both Company Records Operating Cash Flow of $24.4 Million Brings YTD Total to
MAX Power Brings Together Leading Natural Hydrogen Experts for Technical Collaboration and Drill Site Visit GlobeNewswire November 10, 2025 PTRC, University of Regina, Saskatchewan Geological Survey, Colorado School of Mines and the MAX Power Team Convene in Regina to Advance Natural Hydrogen Research and Visit Canada's First Active Drill Site at Lawson Watch the Drill
Atletico de Madrid to Welcome Apollo Sports Capital as Majority Shareholder The Club and leading global sports investor form long-term partnership to support continued growth under CEO Miguel Angel Gil and President Enrique Cerezo GlobeNewswire November 10, 2025 From left to right: Miguel Angel Gil, Enrique Cerezo, Robert Givone MADRID and NEW YORK, Nov. 10,
Kosher Food Market Size to Hit USD 81.23 Billion by 2034, Fueled by Clean-Label and Plant-Based Demand According to Towards FnB, the global kosher food market size is evaluated at USD 44.56 billion in 2025 and is predicted to hit around USD 81.23 billion by 2034, reflecting at a CAGR of 6.9% from 2025 to